Intraocular pressure before and at 3, 6, 9 and 12 months after brinzolamide (1%)/brimonidine (0.1%) fixed combination prescription
Group A | Group B | Group C | |||||||
IOP (mm Hg) | n | P value* | IOP (mm Hg) | n | P value* | IOP (mm Hg) | n | P value* | |
Baseline | 14.1±3.1 | 86 | 15.9±4.0 | 90 | 17.2±4.2 | 123 | |||
3M | 14.0±2.7 | 72 | 0.81 | 14.4±3.4 | 80 | <0.01 | 14.0±2.8 | 102 | <0.0001 |
6M | 14.3±3.4 | 61 | 0.63 | 13.8±4.0 | 74 | <0.01 | 14.1±3.0 | 97 | <0.0001 |
9M | 13.5±3.2 | 50 | 0.13 | 14.1±3.3 | 68 | <0.01 | 14.8±3.0 | 82 | <0.0001 |
12M | 13.8±2.4 | 45 | 0.69 | 14.5±3.7 | 58 | <0.05 | 14.9±3.1 | 66 | <0.0001 |
*Paired t-test.
IOP, intraocular pressure; M, months.